Company intelligence / Profile preview
Nichi-Iko Pharmaceutical
Toyama City, Toyama Prefecture, Japannichiiko.co.jp ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Nichi-Iko Pharmaceutical is one of Japan’s largest and most respected manufacturers of generic drugs and an emerging player in the global biosimilars market. The company has over 480 marketed products, including both small molecules and biologics/biosimilars. Its portfolio addresses diverse therapeutic areas such as oncology, immunology, neurology, urology, cardiology, gastroenterology and more. Notable recent approvals include a bevacizumab biosimilar for colorectal cancer and non-small cell lung cancer. The company maintains robust quality assurance standards with significant R&D investment focused on expanding its pipeline in both Japan and international markets.
- Therapeutic areas
- GastroenterologyPulmonologyCardiovascularUrologyImmunologyOncologyNeurology
- Modalities
- Small moleculeBiologicBiosimilar
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Strategic alliance with Eisai for marketing generics in JapanPartnership with mAbxience for development/commercialization of bevacizumab biosimilars in JapanMedipal HD Group business alliance for distribution/supply chain optimization
Beyond the preview
Go deeper on Nichi-Iko Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nichi-Iko Pharmaceutical.